Tokyo Joe's Cafe / Societe Anonyme/No Pennies Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme/No Pennies

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Troll who wrote (56715)	2/18/1999 8:31:00 PM
From: kha vu	Read Replies (1) of 119973

sepr... SEPR news: as of friday 02/12 M&A rumor mill The Street was abuzz late Friday with the rumor that Johnson & Johnson is considering a bid for partner Sepracor. SEPR shares jumped $15.25 (15 percent) to $114.75 on the week. SEPR and J&J are developing Norastemizole to treat allergic rhinitis and (+)-norcisapride for nocturnal heartburn. SEPR spokesperson Jonae Barnes dismissed the rumor as poppycock, and speculated that the surge could be attributed to a mention of SEPR in Eli Lilly's conference call. Lilly has exclusive worldwide rights to develop SEPR's R-fluoxetine, a modified form of the active ingredient in Lilly's Prozac selective serotonin reuptake inhibitor. Other speculation was Lilly's settlement last week with generics manufacturers over Prozac will give the company more opportunity to focus on the SEPR compound. This is extracted from: biocentury.com SEPR has been widely covered in NYTimes, worth feb 99, wsj... The price target is over $130...but you can play the call options...

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next